Iron Triangle Partners LP's Q2 2021 13F: 9 new positions, 10 exits

Form 13F-HR for the quarter ended Jun 30, 2021 · filed Aug 16, 2021 · 26 reported positions · accession 0001172661-21-001699

What changed this quarter

Iron Triangle Partners LP's changes in reported equity positions, Q2 2021
Activity Security Weight before Weight now Change Shares Shares %
New HUMANA INC (HUM) — 8.3% +8.3 pts +182K sh new
Exited UNITEDHEALTH GROUP INC (UNH) 7.6% — −7.6 pts −160K sh −100%
New CATALENT INC (CTLT) — 6.8% +6.8 pts +608K sh new
New WATERS CORP (WAT) — 6.1% +6.1 pts +170K sh new
Exited LABORATORY CORP AMER HLDGS (LH) 5.5% — −5.5 pts −170K sh −100%
New INTUITIVE SURGICAL INC (ISRG) — 5.2% +5.2 pts +54,999 sh new
Exited HAEMONETICS CORP MASS (HAE) 4.7% — −4.7 pts −330K sh −100%
Exited SURGERY PARTNERS INC (SGRY) 4.1% — −4.1 pts −725K sh −100%
New TENET HEALTHCARE CORP (THC) — 3.3% +3.3 pts +484K sh new
Increased GUARDANT HEALTH INC (GH) 1.9% 4.5% +2.5 pts +250K sh +250%
Increased ABBVIE INC (ABBV) 4.1% 6.2% +2.1 pts +233K sh +78%
Reduced ZIMMER BIOMET HOLDINGS INC (ZBH) 7.5% 3.6% −4.0 pts −155K sh −42%
Exited IQVIA HLDGS INC (IQV) 2.5% — −2.5 pts −100K sh −100%
Exited NATERA INC (NTRA) 1.9% — −1.9 pts −150K sh −100%
New ICON PLC (ICLR) — 1.8% +1.8 pts +85,000 sh new
Increased NEVRO CORP (NVRO) 3.2% 4.8% +1.6 pts +103K sh +57%
Reduced ENCOMPASS HEALTH CORP (EHC) 8.1% 4.5% −3.5 pts −211K sh −27%
Exited EXACT SCIENCES CORP (EXAS) 1.7% — −1.7 pts −100K sh −100%
Increased HORIZON THERAPEUTICS PUB L (HZNP) 5.9% 6.0% +0.1 pts +119K sh +24%
Exited VERICEL CORP (VCEL) 1.1% — −1.1 pts −160K sh −100%
New CANO HEALTH INC (CANO) — 1.1% +1.1 pts +900K sh new
Increased OAK STR HEALTH INC (OSH) 2.4% 3.2% +0.8 pts +186K sh +53%
Increased IDEXX LABS INC (IDXX) 2.2% 3.3% +1.1 pts +15,000 sh +43%
Increased MOLINA HEALTHCARE INC (MOH) 5.9% 6.2% +0.2 pts +37,213 sh +19%
Exited OUTSET MED INC (OM) 0.7% — −0.7 pts −100K sh −100%
Exited ROYALTY PHARMA PLC (RPRX) 0.6% — −0.6 pts −100K sh −100%
Reduced ALIGN TECHNOLOGY INC (ALGN) 4.8% 4.1% −0.7 pts −5,000 sh −7%
Increased CHARLES RIV LABS INTL INC (CRL) 5.2% 5.6% +0.5 pts +7,928 sh +6%
Increased CONMED CORP (CNMD) 3.3% 3.1% −0.2 pts +17,204 sh +9%
Reduced PULMONX CORP (LUNG) 3.5% 2.5% −1.0 pts −50,000 sh −8%
New STEREOTAXIS INC (STXS) — 0.2% +0.2 pts +193K sh new
Increased PACIFIC BIOSCIENCES CALIF IN (PACB) 4.0% 3.5% −0.4 pts +40,440 sh +4%
Reduced ORION ACQUISITION CORP (OHPAU) 1.4% 1.0% −0.4 pts −93,915 sh −9%
New OLINK HLDG AB (OLK) — 0.1% +0.1 pts +25,000 sh new
Reduced ENVISTA HOLDINGS CORPORATION (NVST) 4.7% 4.0% −0.7 pts −10,000 sh −1%

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

Top 10 positions — 59.6% of the equity book

Changes in the top 10 this quarter: HUM entered · CTLT entered · ABBV entered · WAT entered · ISRG entered · NVRO entered · UNH left · ZBH left · LH left · ALGN left · NVST left · HAE left

# Security Weight before Weight now
1 HUMANA INC (HUM) 0.0% 8.3% Entered the top 10
2 CATALENT INC (CTLT) 0.0% 6.8% Entered the top 10
3 MOLINA HEALTHCARE INC (MOH) 5.9% 6.2%
4 ABBVIE INC (ABBV) 4.1% 6.2% Entered the top 10
5 WATERS CORP (WAT) 0.0% 6.1% Entered the top 10
6 HORIZON THERAPEUTICS PUB L (HZNP) 5.9% 6.0%
7 CHARLES RIV LABS INTL INC (CRL) 5.2% 5.6%
8 INTUITIVE SURGICAL INC (ISRG) 0.0% 5.2% Entered the top 10
9 NEVRO CORP (NVRO) 3.2% 4.8% Entered the top 10
10 ENCOMPASS HEALTH CORP (EHC) 8.1% 4.5%
— UNITEDHEALTH GROUP INC (UNH) 7.6% 0.0% Left the top 10
— ZIMMER BIOMET HOLDINGS INC (ZBH) 7.5% 3.6% Left the top 10
— LABORATORY CORP AMER HLDGS (LH) 5.5% 0.0% Left the top 10
— ALIGN TECHNOLOGY INC (ALGN) 4.8% 4.1% Left the top 10
— ENVISTA HOLDINGS CORPORATION (NVST) 4.7% 4.0% Left the top 10
— HAEMONETICS CORP MASS (HAE) 4.7% 0.0% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).